Acorda Therapeutics (16) | Business Finance (8)

Browse by Subcategory

Recent Contracts

Description of Common Stock (Filed With SEC on March 16, 2021)
Asset Purchase Agreement, dated as of January 12, 2021, between the Registrant and Catalent Pharma Solutions, Inc (Filed With SEC on March 16, 2021)
Form of Exchange Agent Agreement, dated as of December 20, 2019, among the Company, the guarantors party thereto, and the holder named therein (Filed With SEC on December 26, 2019)
Security Agreement, dated as of December 23, 2019, from the grantors named therein to Wilmington Trust, National Association, as collateral agent (Filed With SEC on December 26, 2019)
Registration Rights Agreement, dated as of December 20, 2019, among the Company and the investors party thereto (Filed With SEC on December 26, 2019)
Indenture, dated as of December 23, 2019, among the Company, the guarantors party thereto, and Wilmington Trust, National Association, as trustee and collateral agent (Filed With SEC on December 26, 2019)
Specimen stock certificate evidencing shares of common stock (Filed With SEC on March 16, 2021)
Description of Common Stock (Filed With SEC on February 28, 2020)